SARS-CoV-2 viral dynamics in non-human primates

被引:31
|
作者
Goncalves, Antonio [1 ]
Maisonnasse, Pauline [2 ,3 ]
Donati, Flora [4 ,5 ]
Albert, Melanie [4 ,5 ]
Behillil, Sylvie [4 ,5 ]
Contreras, Vanessa [2 ,3 ]
Naninck, Thibaut [2 ,3 ]
Marlin, Romain [2 ,3 ]
Solas, Caroline [6 ]
Pizzorno, Andres [7 ]
Lemaitre, Julien [2 ,3 ]
Kahlaoui, Nidhal [2 ,3 ]
Terrier, Olivier [7 ]
Fang, Raphael Ho Tsong [2 ,3 ]
Enouf, Vincent [4 ,5 ,8 ]
Dereuddre-Bosquet, Nathalie [2 ,3 ]
Brisebarre, Angela [4 ,5 ]
Touret, Franck [9 ]
Chapon, Catherine [2 ,3 ]
Hoen, Bruno [10 ]
Lina, Bruno [7 ,11 ]
Calatrava, Manuel Rosa [7 ]
de Lamballerie, Xavier [9 ]
Mentre, France [1 ]
Le Grand, Roger [2 ,3 ]
van der Werf, Sylvie [4 ,5 ]
Guedj, Jeremie [1 ]
机构
[1] Univ Paris, INSERM, IAME, Paris, France
[2] Univ Paris Saclay, Ctr Immunol Viral Autoimmune Hematol & Bacterial, CEA, INSERM, Fontenay Aux Roses, France
[3] Univ Paris Saclay, Ctr Immunol Viral Autoimmune Hematol & Bacterial, CEA, INSERM, Le Kremlin Bicetre, France
[4] Univ Paris, GMVR Inst Pasteur, Unite Genet Mol Virus ARN, UMR CNRS 3569, Paris, France
[5] Inst Pasteur, Ctr Natl Reference Virus Infect Resp Dont Grippe, Paris, France
[6] Aix Marseille Univ, Hop La Timone, AP HM,Lab Pharmacocinet & Toxicol, Unite Virus Emergents UVE IRD 190,INSERM 1207, Marseille, France
[7] Univ Claude Bernard Lyon 1, Univ Lyon, Ctr Int Rech Infectiol, CIRI,ENS Lyon,Team VirPath,Inserm U1111,CNRS,UMR5, Lyon, France
[8] Inst Pasteur, Pasteur Int Bioresources Network PIBnet, Plate Forme Microbiol Mutualisee P2M, Paris, France
[9] UVE Aix Marseille Univ, Unite Virus Emergents, IHU Mediterranee Infect, IRD 190,INSERM 1207, Marseille, France
[10] Inst Pasteur, Emerging Dis Epidemiol Unit, Paris, France
[11] Hosp Civils Lyon, Grp Hosp Nord, Ctr Natl Reference Virus Infect Resp Dont Grippe, Inst Agents Infect,Lab Virol, Lyon, France
基金
比尔及梅琳达.盖茨基金会;
关键词
PROVIDES INSIGHTS; INFECTION; MODEL;
D O I
10.1371/journal.pcbi.1008785
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Author summary Non-human primates infected with SARS-CoV-2 develop a mild infection resembling asymptomatic human infection. Here we used viral dynamic modelling to characterize the nasopharyngeal and tracheal viral loads. We found that viral load rapidly declined after peak viral load despite the absence of association between model parameters and immune markers. The within-host reproductive basic reproduction number was approximately equal to 6 and 4 in nasopharynx and trachea suggesting that a prophylactic therapy blocking viral entry or production with 90% efficacy could be sufficient to prevent viral growth and peak viral load. Non-human primates infected with SARS-CoV-2 exhibit mild clinical signs. Here we used a mathematical model to characterize in detail the viral dynamics in 31 cynomolgus macaques for which nasopharyngeal and tracheal viral load were frequently assessed. We identified that infected cells had a large burst size (>10(4) virus) and a within-host reproductive basic number of approximately 6 and 4 in nasopharyngeal and tracheal compartment, respectively. After peak viral load, infected cells were rapidly lost with a half-life of 9 hours, with no significant association between cytokine elevation and clearance, leading to a median time to viral clearance of 10 days, consistent with observations in mild human infections. Given these parameter estimates, we predict that a prophylactic treatment blocking 90% of viral production or viral infection could prevent viral growth. In conclusion, our results provide estimates of SARS-CoV-2 viral kinetic parameters in an experimental model of mild infection and they provide means to assess the efficacy of future antiviral treatments.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Immune Status and SARS-CoV-2 Viral Dynamics
    Li, Yijia
    Moser, Carlee
    Aga, Evgenia
    Currier, Judith S.
    Wohl, David A.
    Daar, Eric S.
    Ritz, Justin
    Greninger, Alexander L.
    Sieg, Scott
    Parikh, Urvi M.
    Coombs, Robert W.
    Hughes, Michael D.
    Eron, Joseph J.
    Smith, Davey M.
    Chew, Kara W.
    Li, Jonathan Z.
    JOURNAL OF INFECTIOUS DISEASES, 2023, 228 : S111 - S116
  • [42] Modeling the viral dynamics of SARS-CoV-2 infection
    Wang, Sunpeng
    Pan, Yang
    Wang, Quanyi
    Miao, Hongyu
    Brown, Ashley N.
    Rong, Libin
    MATHEMATICAL BIOSCIENCES, 2020, 328
  • [43] Medical imaging of pulmonary disease in SARS-CoV-2-exposed non-human primates
    Stammes, Marieke A.
    Lee, Ji Hyun
    Meijer, Lisette
    Naninck, Thibaut
    Doyle-Meyers, Lara A.
    White, Alexander G.
    Borish, H. Jacob
    Hartman, Amy L.
    Alvarez, Xavier
    Ganatra, Shashank
    Kaushal, Deepak
    Bohm, Rudolf P.
    le Grand, Roger
    Scanga, Charles A.
    Langermans, Jan A. M.
    Bontrop, Ronald E.
    Finch, Courtney L.
    Flynn, JoAnne L.
    Calcagno, Claudia
    Crozier, Ian
    Kuhn, Jens H.
    TRENDS IN MOLECULAR MEDICINE, 2022, 28 (02) : 123 - 142
  • [44] Predicting the presence of infectious virus from PCR data: A meta-analysis of SARS-CoV-2 in non-human primates
    Snedden, Celine E.
    Lloyd-Smith, James O.
    PLOS PATHOGENS, 2024, 20 (04)
  • [45] Lassa viral dynamics in non-human primates treated with favipiravir or ribavirin
    Lingas, Guillaume
    Rosenke, Kyle
    Safronetz, David
    Guedj, Jeremie
    PLOS COMPUTATIONAL BIOLOGY, 2021, 17 (01)
  • [46] A pathogen-like antigen-based vaccine confers immune protection against SARS-CoV-2 in non-human primates
    Guo, Chang
    Peng, Yanan
    Lin, Lin
    Pan, Xiaoyan
    Fang, Mengqi
    Zhao, Yun
    Bao, Keyan
    Li, Runhan
    Han, Jianbao
    Chen, Jiaorong
    Song, Tian-Zhang
    Feng, Xiao-Li
    Zhou, Yahong
    Zhao, Gan
    Zhang, Leike
    Zheng, Yongtang
    Zhu, Ping
    Hang, Haiying
    Zhang, Linqi
    Hua, Zhaolin
    Deng, Hongyu
    Hou, Baidong
    CELL REPORTS MEDICINE, 2021, 2 (11)
  • [47] SARS-CoV-2 mRNA-vaccine candidate; COReNAPCIN®, induces robust humoral and cellular immunity in mice and non-human primates
    Alimohammadi, Reza
    Porgoo, Meysam
    Eftekhary, Mohamad
    Kiaie, Seyed Hossein
    Ansari Dezfouli, Ehsan
    Dehghani, Maryam
    Nasrollahi, Kaveh
    Malekshahabi, Talieh
    Heidari, Maryam
    Pouya, Sedigheh
    Alimohammadi, Masoumeh
    Sattari Khavas, Dorsa
    Modaresi, Mohammad Sadra
    Ghasemi, Mohammad Hossein
    Ramyar, Hamed
    Mohammadipour, Fatemeh
    Hamzelouei, Fateme
    Mofayezi, Ahmadreza
    Mottaghi, Seyed Saeed
    Rahmati, Amirhosein
    Razzaznian, Mohsen
    Tirandazi, Vista
    Tat, Mahdi
    Borzouee, Fatemeh
    Sadeghi, Hossein
    Haji Mohammadi, Melika
    Rastegar, Leila
    Safar Sajadi, Seyed Milad
    Ehsanbakhsh, Hossein
    Bazmbar, Hamed
    Baghernejadan, Zeinab
    Shams Nouraei, Maedeh
    Pazooki, Pouya
    Pahlavanneshan, Mina
    Alishah, Khadijeh
    Nasiri, Fateme
    Mokhberian, Neda
    Mohammadi, Seyedeh Shima
    Akar, Shima
    Niknam, Hamidreza
    Azizi, Marzieh
    Ajoudanian, Mohammad
    Moteallehi-Ardakani, Mohammad Hossein
    Mousavi Shaegh, Seyed Ali
    Ramezani, Reihaneh
    Salimi, Vahid
    Moazzami, Reza
    Hashemi, Seyed Mahmoud
    Dehghanizadeh, Somaye
    Khoddami, Vahid
    NPJ VACCINES, 2022, 7 (01)
  • [48] Immunogenicity and protective efficacy of a recombinant protein subunit vaccine and an inactivated vaccine against SARS-CoV-2 variants in non-human primates
    He, Qian
    Mao, Qunying
    Peng, Xiaozhong
    He, Zhanlong
    Lu, Shuaiyao
    Zhang, Jialu
    Gao, Fan
    Bian, Lianlian
    An, Chaoqiang
    Yu, Wenhai
    Yang, Fengmei
    Zhou, Yanan
    Yang, Yun
    Li, Yanyan
    Yuan, Yadi
    Yan, Xujia
    Yang, Jinghuan
    Wu, Xing
    Huang, Weijin
    Li, Changgui
    Wang, Junzhi
    Liang, Zhenglun
    Xu, Miao
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
  • [49] SARS-CoV-2 induces inflammation and intracranial infection through the olfactory epithelium-olfactory bulb pathway in non-human primates
    Shimizu, Shino
    Nakayama, Misako
    Nguyen, Cong Thanh
    Ishigaki, Hirohito
    Kitagawa, Yoshinori
    Yasui, Fumihiko
    Yagi, Yoshiki
    Kusayanagi, Tomoe
    Kohara, Michinori
    Itoh, Yasushi
    Tojima, Ichiro
    Kouzaki, Hideaki
    Shimizu, Takeshi
    JOURNAL OF NEUROIMMUNOLOGY, 2024, 387
  • [50] Immunogenicity and protective efficacy of a recombinant protein subunit vaccine and an inactivated vaccine against SARS-CoV-2 variants in non-human primates
    Qian He
    Qunying Mao
    Xiaozhong Peng
    Zhanlong He
    Shuaiyao Lu
    Jialu Zhang
    Fan Gao
    Lianlian Bian
    Chaoqiang An
    Wenhai Yu
    Fengmei Yang
    Yanan Zhou
    Yun Yang
    Yanyan Li
    Yadi Yuan
    Xujia Yan
    Jinghuan Yang
    Xing Wu
    Weijin Huang
    Changgui Li
    Junzhi Wang
    Zhenglun Liang
    Miao Xu
    Signal Transduction and Targeted Therapy, 7